Kinnate Biopharma Inc.
Inhibitors of cyclin-dependent kinases
Last updated:
Abstract:
Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Status:
Grant
Type:
Utility
Filling date:
2 May 2019
Issue date:
20 Sep 2022